SEC Form 4 · accession 0001193125-26-267996
Korro Bio, Inc. · KRRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Francois Formela
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 11, 2026 · 5:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703647
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.59 | Jun 10, 2026 | A | 14,677 | A | — | Jun 9, 2036 | Common Stock | 14,677 | 14,677 | D |
Explanation of responses
- F1The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.